Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin
Amir Hossein Doustimotlagh, Mahdieh Eftekhari
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Glucose-6-phosphate dehydrogenaseDehydrogenasePhosphate2019-20 coronavirus outbreakPharmacologyInternal medicineVirologyBiochemistryEnzymeDiseaseChemistryInfectious disease (medical specialty)OutbreakNeonatal Health and BiochemistryPARP inhibition in cancer therapyCOVID-19 Clinical Research Studies